학술논문

Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JUL 1 2022, 28 13, p2762-p2770, 9p.
Subject
Language
English
ISSN
15573265